A Drug-Drug Interaction Study Between Danoprevir/Low-dose Ritonavir and Cyclosporine, a Potent Inhibitor of OATP, in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Danoprevir (Primary) ; Ciclosporin; Ritonavir
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- Sponsors Roche
- 16 Apr 2012 Actual patient number 18 added as reported by ClinicalTrials.gov.
- 16 Apr 2012 Actual end date 1 Apr 2012 added as reported by ClinicalTrials.gov.
- 16 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History